Literature DB >> 3340823

Lymph-borne dendritic leucocytes do not recirculate, but enter the lymph node paracortex to become interdigitating cells.

S Fossum1.   

Abstract

Peripheral lymph contains constitutively major histocompatibility complex (MHC) class II-positive, dendritic leucocytes (DL) with a veiled (VC) or dendritic (DC) shape. On the basis of phenotypic similarities to the interdigitating cells (IDC) of T-dependent areas of lymphoid tissues, they are believed, but not yet proven, to be IDC precursors that develop into mature IDC within the draining lymph nodes. In order to determine the relationship between VC/DC and IDC, highly purified radiolabelled peripheral lymph DL (collected by thoracic duct cannulation of mesenteric lymphadenectomized congenitally athymic, nude rats) were reinjected into the veins or footpads of syngeneic recipients. Later, host blood and lymph were collected and the tissues were biopsied and processed for scintillation counting or for light microscopic autoradiography combined with electron microscopy of neighbouring sections. The intravenously injected VC/DC did not enter lymph nodes or Peyer's patches directly from blood and did not re-enter the lamina propria of the gut, but became localized largely in the liver and the spleen. From the liver some of the cells proceeded via afferent lymphatics to the liver and the spleen. From the liver some of the cells proceeded via afferent lymphatics to the coeliac lymph nodes. Similarly, some of the locally injected cells were carried with peripheral lymph to the draining popliteal lymph nodes, although most were retained in the footpads. In the spleen the VC/DC entered the periarteriolar lymphoid sheaths and in the coeliac and popliteal lymph nodes they became localized in the paracortex, where they acquired the morphology of mature IDC.

Entities:  

Mesh:

Year:  1988        PMID: 3340823     DOI: 10.1111/j.1365-3083.1988.tb02326.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  29 in total

1.  Identification of lectin-like receptors expressed by antigen presenting cells and neutrophils and their mapping to a novel gene complex.

Authors:  Line Mari Flornes; Yenan T Bryceson; Anne Spurkland; Johnny C Lorentzen; Erik Dissen; Sigbjørn Fossum
Journal:  Immunogenetics       Date:  2004-09-11       Impact factor: 2.846

Review 2.  The role of graft-derived dendritic leukocytes in the rejection of vascularized organ allografts. Recent findings on the migration and function of dendritic leukocytes after transplantation.

Authors:  C P Larsen; J M Austyn; P J Morris
Journal:  Ann Surg       Date:  1990-09       Impact factor: 12.969

3.  Activation of bone marrow-resident memory T cells by circulating, antigen-bearing dendritic cells.

Authors:  Lois L Cavanagh; Roberto Bonasio; Irina B Mazo; Cornelia Halin; Guiying Cheng; Adrianus W M van der Velden; Annaiah Cariappa; Catherine Chase; Paul Russell; Michael N Starnbach; Pandelakis A Koni; Shiv Pillai; Wolfgang Weninger; Ulrich H von Andrian
Journal:  Nat Immunol       Date:  2005-09-11       Impact factor: 25.606

4.  Lymph-borne (veiled) dendritic cells can acquire and present intestinally administered antigens.

Authors:  L M Liu; G G MacPherson
Journal:  Immunology       Date:  1991-07       Impact factor: 7.397

5.  Deficient responsiveness of ovine popliteal peripheral lymphocytes.

Authors:  M Brenan
Journal:  Immunology       Date:  1990-01       Impact factor: 7.397

6.  Analysis of mouse dendritic cell migration in vivo upon subcutaneous and intravenous injection.

Authors:  M B Lappin; J M Weiss; V Delattre; B Mai; H Dittmar; C Maier; K Manke; S Grabbe; S Martin; J C Simon
Journal:  Immunology       Date:  1999-10       Impact factor: 7.397

7.  Dendritic cells route human immunodeficiency virus to lymph nodes after vaginal or intravenous administration to mice.

Authors:  C Masurier; B Salomon; N Guettari; C Pioche; F Lachapelle; M Guigon; D Klatzmann
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

Review 8.  Dendritic cell biology and the application of dendritic cells to immunotherapy of multiple myeloma.

Authors:  R Hájek; A W Butch
Journal:  Med Oncol       Date:  2000-02       Impact factor: 3.064

Review 9.  Current immunotherapeutic strategies for central nervous system tumors.

Authors:  Medina C Kushen; Adam M Sonabend; Maciej S Lesniak
Journal:  Surg Oncol Clin N Am       Date:  2007-10       Impact factor: 3.495

10.  In vivo effects of thymostimulin treatment on monocyte polarization, dendritic cell clustering and serum p15E-like trans-membrane factors in operable head and neck squamous cell carcinoma patients.

Authors:  J D Kerrebijn; P J Simons; M Tas; A J Balm; H A Drexhage
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.